Showing 1-6 of 6 grants

Title Institution Researcher Program Duration Total Award Amount
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) AdventHealth Richard Pratley Improving Lives 01-September-2023 to 20-November-2026 $110,840.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850,000.00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-August-2026 $750,000.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D University of Florida Graciela Lorca Cures 01-September-2019 to 31-August-2026 $355,941.78
Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression University of Florida Sarah Kim Cures 01-June-2022 to 31-May-2026 $744,090.11